Access Statistics for James Mason

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Evaluating change in professional behaviour: issues in design and analysis 0 0 0 30 1 1 3 182
NICEly does it: economic analysis within evidence-based clinical practice guidelines 0 0 0 25 0 0 1 148
Optometrist prescribing of therapeutic agents: economic implications for the UK 0 0 0 35 2 2 3 237
Screening for diabetic retinopathy by optometrists: effectiveness and cost-effectiveness 1 1 1 60 1 2 4 402
The DH register of cost-effectiveness studies: a review of study content and quality 0 0 0 28 0 0 5 99
Topical preparations for the treatment of psoriasis in primary care: a systematic review 0 0 0 36 0 1 5 311
Total Working Papers 1 1 1 214 4 6 21 1,379


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A framework for incorporating cost-effectiveness in evidence-based clinical practice guidelines 0 0 0 8 0 0 0 32
Biotechnology: a special case for health technology assessment? 0 0 0 8 0 0 0 35
Compassionate containment? Balancing technical safety and therapy in the design of psychiatric wards 0 0 0 0 0 0 0 22
Cost-effectiveness league tables: More harm than good? 0 0 6 52 0 0 11 121
Cost-effectiveness league tables: think of the fans 0 0 2 15 0 0 2 50
Creating ‘therapeutic landscapes’ for mental health carers in inpatient settings: A dynamic perspective on permeability and inclusivity 0 0 0 1 0 0 0 19
Methodological Issues Surrounding the Use of Baseline Health-Related Quality of Life Data to Inform Trial-Based Economic Evaluations of Interventions Within Emergency and Critical Care Settings: A Systematic Literature Review 0 0 0 0 0 0 2 13
Optometrist prescribing of therapeutic agents: findings of the AESOP survey 0 0 0 12 0 0 0 45
Spaces for smoking in a psychiatric hospital: Social capital, resistance to control, and significance for ‘therapeutic landscapes’ 0 0 0 0 0 0 0 14
The Importance of Achieving Additional Drug Benefits at a Reasonable Cost 0 0 0 3 0 0 1 66
Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal 0 0 0 0 1 1 2 4
Total Journal Articles 0 0 8 99 1 1 18 421


Statistics updated 2019-09-09